Left Menu
Development News Edition

India conveys concerns to Pak on possible attempts to disrupt Kartarpur Sahib pilgrimage

PTI | New Delhi | Updated: 14-07-2019 18:25 IST | Created: 14-07-2019 18:14 IST
India conveys concerns to Pak on possible attempts to disrupt Kartarpur Sahib pilgrimage
Image Credit: IANS

India on Sunday handed over a dossier to Pakistan about Pakistan-based individuals and organisations who might try to disrupt pilgrimage to the Kartarpur Sahib Gurudwara, following which Islamabad assured that no anti-India activity would be allowed. The government also said that Pakistan has "in-principle agreed" to build a bridge to connect with the Indian side and to visa-free travel for Indian passport holders and OCI card-holders.

India flagged its security concerns during a meeting that took place between delegations of the two countries on the Pakistani side of the Attari-Wagah border to discuss the modalities of the Kartarpur corridor. New Delhi had earlier conveyed its strong concerns to Pakistan over the presence of a leading Khalistani separatist in a committee appointed by Islamabad on the project.

After the second round of talks on the project, Home Ministry Joint Secretary S C L Das said Pakistani officials confirmed that controversial Sikh leader Gopal Singh Chawla had been dropped from various bodies, including as secretary-general of Pakistan Sikh Gurdwara Parbandhik Committee (PSGPC). "We have shared our concerns regarding individuals or organisations based in Pakistan who may try to disrupt the pilgrimage and misuse the opportunity," he told a press conference at the Attari border on the Indian side

"To highlight the concerns, we handed over a dossier today containing information about these organisations and individuals which may pose a kind of potential threat to our pilgrims. We have handed this over with a request that they seriously act upon it," Das said. The Pakistan side assured the delegation that no anti-India activity would be allowed, the joint secretary, who headed the Indian delegation, said.

On Chawla, Das said, "We had sought confirmation that individuals like Gopal Singh Chawla were removed from the bodies to which we had raised an objection. So they confirmed in that Chawla had been removed from PSGPC and other bodies." He said the Pakistani side was apprised of the ban imposed by Government of India on the US-based pro-Khalistan outfit 'Sikhs for Justice'.

"We told them that we have declared this organisation (SFJ) unlawful and given them our gazette notification banning it. We told them we have information that this organisation is also operating from their land," he said. The Indian delegation also sought consular presence in the Kartarpur Sahib Gurudwara to be able to provide assistance to pilgrims, if required, a statement by the External Affairs Ministry said.

India urged Pakistan to take into consideration the sentiments of pilgrims to have smooth, easy and unrestricted access to the gurdwara throughout the year, he said. The Indian delegation comprised representatives from the Home Ministry, External Affairs Ministry, Defence Ministry, the Punjab government and the National Highway Authorities of India.

The statement said progress was made in finalising the draft agreement with regard to the modalities. "It was agreed to allow visa-free travel for the Indian passport holders and OCI cardholders seven days a week. Throughout the year, 5000 pilgrims will be allowed to visit Kartarpur Sahib Gurudwara per day. The pilgrims will be allowed to travel as individuals or in groups and also on foot," it added.

India has been urging Pakistan that 5,000 pilgrims be allowed to visit the gurudwara every day and 10,000 additional pilgrims are allowed on special occasions with no restriction in terms of faith. Das said the delegation raised the issue of encroachment and acquisition of land belonging to the gurdwara.

"We have requested Pakistan to honour religious sentiments and remove the encroachment, besides restoring the encroached land to the gurdwara," he said. The statement said Pakistan has agreed to look into the issue.

The work on the four-lane highway to the crossing point at the International Boundary is progressing well and is on schedule, officials said. It will be completed by the end of September. India is also constructing a state-of-the-art construction passenger terminal facility that can accommodate 15,000 passengers, they said.

The bone of contention is connecting the two sides at the zero points which were also discussed. India is constructing a bridge at the zero points and has urged Pakistan to build a similar bridge on its side that will provide safe and secure movement of pilgrims and address concerns regarding flooding.

Another option proposed by Pakistan is building a causeway which is also not acceptable to India as it has been insisting on an all-weather bridge. The bridge is over a creek of which the majority part falls in Pakistan. The Indian delegation shared detailed flood analysis to Pakistan to highlight these concerns.

The Indian delegation said earth-filled embankment or a causeway proposed by Pakistan will create problems for its people and this should not be built even in the interim. "Pakistan side agreed, in principle, to build a bridge at the earliest," it said.

"Pending the construction of a bridge over the old Ravi creek by Pakistan on their territory, India offered to make interim arrangements for making the corridor operational in November, given the historic importance of the 550th birth anniversary of Guru Nanak Dev," it added. Das expressed confidence that India would be ready to commence the pilgrimage to Kartarpur Sahib on the auspicious occasion.



How UK’s 'best prepared' healthcare system failed to gauge COVID-19

The UK is proud of their public health system and its unlike any other country as around 90 percent of British public supports the founding principles of National Health Service. But without accurate data being available to stakeholders in ...

Poor on IHR capacity progress in 2019, WHO says Cambodia tops COVID-19 response

Despite being in proximity to Hubei, the original epicenter of COVID-19 pandemic, Cambodia has reported just 226 confirmed cases and zero deaths. After seeing the data, WHO appreciated Cambodias healthcare information system but experts dou...

Loopholes in Healthcare Information System may have failed Singapore COVID-19 model

In the initial days of the COVID-19 outbreak, Singapore was in the limelight for its effective healthcare system and pandemic response plan. However, Singapore has now joined the list of the worst-hit nations and the situation is even worse...

Australia's COVID-19 response: Digital infrastructure of help but implementation remains a challenge

Australias ongoing plans to upgrade its health information system helped by the Digital Health Strategy seem even more practical due to the pandemic. But as evident during the pandemic, administrative lapses and the complex matrix of power ...


Latest News

India's Wockhardt to supply millions of doses of COVID-19 vaccines to UK

Indian drugmaker Wockhardt Ltd will supply millions of doses of multiple COVID-19 vaccines to the UK, including the one being developed by AstraZeneca and Oxford University, it said on Monday.The company has reserved fill-and-finish capacit...

Rising real lending rate roiling RBI rate cuts, scuppering credit offtake and growth: Report

Even after the Reserve Bank has slashed the key interest rates by 135 basis points bps since February this year, the real lending rates have only gone up by 44 bps in spite of nominal lending rates falling by 105 bps during the same period,...

Jharkhand CM greets people on Raksha Bandhan

Jharkhand Chief Minister Hemant Soren on Monday greeted people on the occasion of RakshaBandhanThe chief minister also advised the people tocelebrate the festival by staying at home in view ofCOVID-19 outbreakTaking to Twitter, Soren said, ...

Rival drugmakers launch joint trial of medicines for COVID-19

Rival drugmakers AbbVie Inc, Amgen Inc and Takeda Pharmaceuticals Inc on Monday said they have begun treating patients in a trial to quickly show whether a drug from each company can be repurposed and used against COVID-19, the disease caus...

Give Feedback